AI Scribes May Save Time, but New Evidence Suggests Quality Still Varies
A report from the AAFP says custom AI scribes can deliver a return on investment in small practices, highlighting the financial appeal of documentation automation. But a separate study found AI scribe tools can produce lower-quality notes than human clinicians, underscoring the tradeoff between speed and fidelity.
AI scribes are one of the clearest examples of health AI’s near-term promise: less documentation burden, more face time with patients, and a business case that can be measured in hours saved. For small practices, that promise can be especially compelling.
Yet the emerging evidence suggests the category should not be judged on efficiency alone. If an AI note is faster to produce but less accurate, less complete, or less clinically useful, the apparent productivity gain may create downstream costs in review time, coding quality, or care continuity.
That makes the ROI conversation more complicated than vendors often imply. The right question is not simply whether AI scribes save money, but where the savings come from and who absorbs the risk if the note is wrong. In smaller practices, there may be fewer safeguards and less margin for error.
The contrast between financial upside and quality concerns is becoming a recurring theme in healthcare automation. Tools often improve throughput before they improve trust, which means adoption frequently outpaces governance.
The result is a market that is still learning how to measure value properly. The winners in AI documentation will likely be the systems that show not just labor savings, but measurable reliability, clinician satisfaction, and downstream safety.